2012
DOI: 10.1016/j.fsi.2011.11.030
|View full text |Cite
|
Sign up to set email alerts
|

Immune responses and protection in catla (Catla catla) vaccinated against epizootic ulcerative syndrome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
7
1

Year Published

2013
2013
2022
2022

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 23 publications
(9 citation statements)
references
References 24 publications
0
7
1
Order By: Relevance
“…Importantly, 100% mortality was observed in both groups of fish. In contrast to our findings, Saikia and Kamilya (2012) reported that there was reduction in the mortality percentage of the immunised group of fish, but it was not statistically significant (p>0.05). The authors suggested that one of the reasons for not showing significantly higher protection against A. invadans in the immunised groups could be that secondary immunisation was not performed in their experiment.…”
contrasting
confidence: 99%
See 3 more Smart Citations
“…Importantly, 100% mortality was observed in both groups of fish. In contrast to our findings, Saikia and Kamilya (2012) reported that there was reduction in the mortality percentage of the immunised group of fish, but it was not statistically significant (p>0.05). The authors suggested that one of the reasons for not showing significantly higher protection against A. invadans in the immunised groups could be that secondary immunisation was not performed in their experiment.…”
contrasting
confidence: 99%
“…However, in the present study, fish were given a booster dose following primary immunisation and were challenged with less number of zoospores i.e. 100 zoospores per fish compared to 20000 zoospores by Saikia and Kamilya (2012). Therefore, it can be concluded that it may not be easy to induce protective immunity following immunisation with conventional antigenic preparations A. invadans.…”
mentioning
confidence: 65%
See 2 more Smart Citations
“…At present there are no direct competitors for commercial fish-vaccines other than universities (Dipangka & Dibyendu, 2012;Harikrishnan, Balasundaram, & Heo, 2012;Maiti et al, 2012;Rajesh Kumar et al, 2008) and research institutes (Behera & Swain, 2012;Swain et al, 2010) which provide experimental vaccines. The most likely competitors in India are substitute manufacturers such as Hindustan Ciba-Geigy Ltd, Glaxo Laboratories, etc., who are supplying chemotherapeutic agents for aquaculture enterprises (Pathak, Ghosh, & Palanisamy, 2000).…”
Section: The Competitive Landscape In the Fish Vaccines Segment In Indiamentioning
confidence: 99%